CD274 and cancer: In addition, the mechanism that the interaction of tumor-infiltrating lymphocytes expressing PD-1 and PD-L1 undermine antitumor immunity is generally adopted by cancer immunotherapy (Wang et al., 2014; Kurozumi et al., 2017).